To define safety and efficacy of a palliative, short-course accelerated radiation therapy for symptomatic locally advanced primary pelvic cancer.
Palliative short-course radiotherapy in advanced pelvic cancer: A phase II study (SHARON project) / Farina E.; Macchia G.; Siepe G.; Zamagni A.; Buwenge M.; Scirocco E.; Cellini F.; Deressa B.T.; Tigeneh W.; Uddin K.A.F.M.; Sumon M.A.; Caravatta L.; Genovesi D.; Mauro F.A.; Cammelli S.; Cilla S.; Morganti A.G.; Deodato F.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - ELETTRONICO. - 39:8(2019), pp. 4237-4242. [10.21873/anticanres.13585]
Palliative short-course radiotherapy in advanced pelvic cancer: A phase II study (SHARON project)
Zamagni A.;Buwenge M.;Cammelli S.;Morganti A. G.;
2019
Abstract
To define safety and efficacy of a palliative, short-course accelerated radiation therapy for symptomatic locally advanced primary pelvic cancer.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
